BiondVax Pharmaceuticals Ltd.
BVXVW
BVXVW was delisted on the 13th of May, 2020.
4 hedge funds and large institutions have $46K invested in BiondVax Pharmaceuticals Ltd. in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
64% less capital invested
Capital invested by funds: $127K → $46K (-$81K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mariner
Overland Park,
Kansas
|
+$11.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$481 |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$96 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $31K | – | – | – |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $9K | -$481 | -500 | -2% |
|
|
3
Mariner
Overland Park,
Kansas
| $5K | +$11.5K | +12,000 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $1K | -$96 | -100 | -8% |
|
BVXVW Hedge Fund Activity: Q4 2018 in Review
4 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in BiondVax Pharmaceuticals Ltd. (BVXVW) for Q4 2018, worth a combined $46K — down 64% from $127K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BVXVW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Mariner, opening a new position worth an estimated $11.5K. The largest seller was Susquehanna International Group, cutting an estimated $481.
- 4 institutional investors held BiondVax Pharmaceuticals Ltd. (BVXVW) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $46K of BiondVax Pharmaceuticals Ltd. stock for Q4 2018, down 64% quarter-over-quarter.
- 1 fund opened new BiondVax Pharmaceuticals Ltd. positions in Q4 2018 and 0 closed out, a net change of +1 holder.
- The largest BiondVax Pharmaceuticals Ltd. buyer in Q4 2018 was Mariner, an estimated $11.5K added.
- The largest BiondVax Pharmaceuticals Ltd. seller in Q4 2018 was Susquehanna International Group, an estimated $481 sold.
Based on aggregated 13F filings for Q4 2018.